Completed
A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons
NCT00002130
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- UCLA School of Medicine Los Angeles, California, United States
- AIDS Research Consortium of Atlanta Atlanta, Georgia, United States